Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update
Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4 HIMS stock today: price, move and context As of early afternoon on Friday, November 14, 2025, Hims & Hers shares are: Trading has been volatile around HIMS in recent sessions,